Thomas M. Idzorek, CFA, is the author of “Personalized Multiple Account Portfolio Optimization,” for the Financial Analysts Journal, and co-author of Popularity: A Bridge between Classical and Behavioral Finance, from the CFA Institute Research Foundation. Like many topics that inspire passion and thoughtful debate, environmental, social, and governance (ESG) investing is complex and multifaceted. Unfortunately, at least in the United States, ESG investing has become politicized, which makes nuanced perspective and analysis more and more difficult. If only there were an economic theory we could leverage to rise above the binary, politicized landscape, that would help us understand the different impacts…
Author: user
Passive investing in index funds can generate returns that roughly match the overall market. But investors can boost returns by picking market-beating companies to own shares in. To wit, the Zebra Technologies Corporation (NASDAQ:ZBRA) share price is 83% higher than it was a year ago, much better than the market return of around 38% (not including dividends) in the same period. So that should have shareholders smiling. Zooming out, the stock is actually down 29% in the last three years.Now it’s worth having a look at the company’s fundamentals too, because that will help us determine if the long term…
Shirley Temple, the beloved child actress of the 1930s and 1940s, is celebrated for various iconic contributions to American culture, including her famous song “On the Good Ship Lollipop,” her tap-dancing performances with Bill “Bojangles” Robinson, and the non-alcoholic drink that shares her name. Recently, a limited-edition version of this drink has been launched under the 7Up brand. However, her legacy extends beyond her early career in Hollywood; she also played a significant role in U.S. diplomacy, serving as the Ambassador to Czechoslovakia during a pivotal moment in history—the fall of the Berlin Wall. At the center of this story…
CARSON CITY, Nev. – BioVie Inc. (NASDAQ: BIVI), a clinical-stage biopharmaceutical company, today disclosed the launch of a registered direct offering, aiming to raise approximately $6.7 million through the sale of common stock and warrants. The transaction involves the issuance of 4,443,000 shares at a price of $1.50 each, alongside warrants to purchase an equivalent number of shares at $1.37 per share. The warrants, which become exercisable six months post-issuance, will expire five years from the initial exercise date. BioVie anticipates the offering to close around October 22, 2024, subject to customary closing conditions. ThinkEquity is serving as the sole…
The Mercedes-Benz convertible lineup has undergone significant changes over the past decade, evolving from a range of somewhat uniform models to a more focused selection. Today, the lineup consists of just two offerings: the luxury SL roadster and the newly introduced CLE Cabriolet, which is now available in a performance-oriented Mercedes-AMG CLE53 trim. This shift reflects Mercedes’ commitment to enhancing both luxury and performance, highlighting a clearer distinction between its models. The CLE Cabriolet is built on the MRA2 platform and is available as both a coupe and convertible, effectively consolidating features from the previous C- and E-class two-door models.…
(Bloomberg) — Yesterday they dealt in distressed debt, today they’re battling to establish credibility as plain-vanilla lenders.Most Read from BloombergMoney managers once known for providing capital to businesses that couldn’t get bank financing are vying to lend to the world’s top-rated companies.Blackstone Inc. has more than $90 billion of investment-grade private credit assets, up roughly 40% from a year ago. The firm expects that to grow.Apollo Global Management Inc. is also putting more resources into writing bigger checks to finance investment-grade companies. In the past four years, it originated about $100 billion through its “high grade capital solutions” business that…
Toto Wolff has raised concerns about the inconsistent decisions made by the stewards during the United States Grand Prix, specifically highlighting the penalties issued to George Russell and Lando Norris. He described Russell’s five-second penalty for forcing Valtteri Bottas off the track as a “joke.” This sentiment was echoed by McLaren, who was upset over Norris’s penalty, suggesting a broader issue of bias in the stewards’ decision-making process. During the race, Russell and Yuki Tsunoda both received penalties for similar incidents, while Max Verstappen escaped without sanctions after forcing Norris off the track. This inconsistency led Wolff to question the…
Tesla Quietly Transfers $765 Million In Bitcoin, Putting Musk’s Cryptocurrency Strategy Under Intense Scrutiny Amid Market ConcernsElon Musk’s ventures into cryptocurrency are raising eyebrows once again. Blockchain analytics firm Arkham Intelligence reported that Tesla recently moved about $765 million worth of Bitcoin to unidentified wallets.This massive transfer has sparked a flurry of speculation. What’s Tesla planning next? Will they sell or is there something else at play? Tesla hasn’t commented, leaving experts and crypto-watchers alike in suspense.Don’t Miss:According to BitcoinTreasuries, Tesla holds the fourth-largest stash of Bitcoin among U.S. public companies. Only MicroStrategy and crypto mining giants like MARA Holdings…
Image source: Getty Images As I look around for passive income stocks to buy, there remain plenty of great candidates in the FTSE 100. Here are two I’ve currently got my eye on, especially as both go ex-dividend next month. Passive income powerhouse International distributor Bunzl (LSE: BNZL) is one of the most consistent stocks in the UK market when it comes to cash returns. We’re talking year after year of consecutive rises to the total dividend. Much of this is down to it supplying the sort of things businesses always need. We’re talking food packaging, cleaning chemicals, and safety…
In a challenging market environment, Cross Country Healthcare, Inc. (NASDAQ:) stock has touched a 52-week low, reaching a price level of $11.98. This downturn reflects a significant retreat from previous valuations, marking a stark contrast to the company’s performance over the past year. Investors have witnessed a substantial decline in the stock’s value, with Cross Country experiencing a -46.86% change over the one-year period. This decrease underscores the volatility and pressures faced by the healthcare staffing industry, as well as the broader economic factors influencing investor sentiment. In other recent news, Cross Country Healthcare, Inc. posted robust second quarter results…